Quest Diagnostics (DGX) PT Lowered to $125 at Citi, Downgraded to Sell

November 17, 2022 5:05 AM EST Send to a Friend
(Updated - November 17, 2022 5:06 AM EST)

Citi analyst Ralph Giacobbe lowered the price target on Quest Diagnostics ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login